Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep1089 | Thyroid cancer | ECE2016

Malignancy in AUS/FLUS: can we create a predictive score?

Silva Silvia , Rafael Ana , Marques Ricardo , Fernandes Luis

Background: Thyroid AUS/FLUS lesions continue to be a grey area regarding the surgery to be carried out. Our aim was to create a predictive malignancy score to help in surgical decision.Methods: Retrospective study of 2981 patients and 3557 thyroid Fine-needle aspirations (FNAs) between January 2012 to December 2014. Ultrasound and cytological findings considered suspicious by the ATA guidelines were analyzed. Malignant group was compared with a control ...

ea0020p257 | Bone/Calcium | ECE2009

Primary hyperparathyroidism surgery: team report 2002–2008

Allen Miguel , Rafael Ana , Xio Carlos , Fernandes Luis , Torrinha Joaquim

Introduction: Single adenoma is the most frequent cause of Primary hyperparathyroidism (HPT1). Surgical excision has a high success rate, particularly when associated with a fast intraoperative intact parathyroid hormone assay (PTHi).Aim: Evaluate the success rate of primary hyperparathyroidism surgery in our unit.Methods: Descriptive study of the last 33 consecutive HPT1 patients who undertook surgery, 27 of which with PTHi. The P...

ea0041gp203 | Thyroid - Translational & Clinical | ECE2016

Repeating FNA in AUS/FLUS – is it necessary?

Alves Rafael Ana , Rodrigues Marques Ricardo , Sofia Silva Silvia , Viana Fernandes Luis

Background: The review of the Bethesda System Classification has brought some challenge to the clinical role of category III lesions. Repeating fine-needle aspiration (FNA) is time-consuming, painful, brings additional cost and sometimes does not change the clinical decision. Our aim was to prove if there is true benefit in repeating FNA.Methods: Retrospective review of 4549 thyroid FNAs between January 2012 and June 2015, from which 671 classified as AU...

ea0041ep966 | Thyroid (non-cancer) | ECE2016

What does matter for AUS/FLUS: size, sex or age?

Rafael Ana Alves , Silva Silvia , Marques Ricardo Rodrigues , Duarte Joao Sequeira , Fernandes Luis Viana

Background: The clinical attitude to the treatment of Bethesda System Category III lesions has been under controversy. Our aim was to analyse three variables and to establish a possible predictive value for carcinoma in patients with AUS/FLUS nodules.Methods: Retrospective study of 671 thyroid fine-needle aspirations (FNAs) classified as AUS/FLUS between January 2012 and June 2015. Size, sex and age were analysed, using SPSS.Result...

ea0067gp20 | Poster Presentations | EYES2019

Pheochromocytoma, unmasking the chameleon

Cunha Clara , Ferrinho Catia , Santos Francisco Sousa , Silva Eugenia , Fernandes Luis Viana , Saraiva Catarina , Oliveira Manuela , Duarte Joao Sequeira

Background: Pheochromocytoma is a rare catecholamine secreting tumor originating usually from adrenal medulla and representing approximately 5% of adrenal incidentalomas. Currently 10% of all pheochromocytomas are discovered incidentally during imaging studies for unrelated disorders.Case presentation: A thirty five year old woman with no relevant medical history presented at the emergency department with symptoms of left flank pain and vomiting. Abdomin...

ea0049gp222 | Thyroid 3 | ECE2017

Will it be useful to measure PTH at 4 hours post thyroidectomy to decide for calcium replacement? 1st result of a prospective study

Silva Silvia , Rafael Ana , Marques Ricardo , Moniz Luisa , Costa Carlos , Capitao Ricardo , Saraiva Catarina , Limbert Clotilde , Fernandes Luis , Matias Rogerio

Introduction: Calcium replacement after Thyroid surgery has been changing along times. The aim for this replacement is to avoid hypocalcaemia effects after thyroid surgery but not all the patients seem to need it. Parathyroid hormone (PTH) has a short half-life after its release into the bloodstream, making it a good marker of calcium metabolism in short time after surgery.Method: Prospective study of Endocrine Surgery Multidisciplinary group of one Cent...

ea0041ep1150 | Thyroid cancer | ECE2016

Can we predict malignancy in AUS/FLUS by measuring TSH?

Marques Ricardo Rodrigues , Rafael Ana Alves , Santos Francisco Sousa , Silva Silvia Sofia , Duarte Joao Sequeira , Fernandes Luis Viana

Background: Fine-needle aspiration (FNA) is an important test for triaging patients with thyroid nodules and differentiating benign from malignant disease. According to Bethesda System Classification, the rate of AUS/FLUS is between 3–6% of all FNA. The malignancy risk is of 5–15%. TSH levels might be associated to the likelihood of malignancy in thyroid nodules according to some studies. Our aim was to establish a possible correlation between TSH level and malignanc...